Saxagliptin API
Saxagliptin is a highly effective dipeptidase -4 inhibitor. By selectively inhibiting dpp-4, endo ... Read More
It can be very good proliferation of NMF content in the skin, penetrate the stratum corneum, make the skin more moist sense; Improve skin elasticity and softness; Promote the growth of fibrous cells, improve skin health and improve skin quality; Slow release conveying system enables skin to better absorb various effective ingredients.
Market Analysis and Insights: Global Sodium Polyglutamate Market
The global Sodium Polyglutamate market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Sodium Polyglutamate Scope and Market Size
The global Sodium Polyglutamate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sodium Polyglutamate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Purity≥90%
Purity≥95%
Segment by Application
Face Cream
Emulsion
Mask
Other
The Sodium Polyglutamate market is analysed and market size information is provided by regions (countries). Segment by Application, the Sodium Polyglutamate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Vedan
Gis Creos
Shandong Fruida
Jarchem Innovative Ingredients
Beijing Brilliance Biochemical
Coach Chem
Nanjing Xuankai Biotech
Shandong Haibier
Saxagliptin is a highly effective dipeptidase -4 inhibitor. By selectively inhibiting dpp-4, endo ... Read More
Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocke ... Read More
Candesartan is a drug substance for antihypertensive drugs.CAS number is 145040-37-5.
Read More
It is an alpha1 adrenergic antagonist indicated for:Signs and symptoms of Benign Prostatic Hyperp ... Read More